Main Article Content
Background. Hypoglycemic therapy used at present in patients with type 2 diabetes mellitus (DM) does not always lead to desired result and many patients live in a state of constant decompensation of metabolic processes, with the high levels of glycemia and glycosuria. That is why the search for the optimal treatment strategy that could increase the effectiveness of hypoglycemic therapy, and reduce the risk of complications is one of the most actual problems of modern diabetology.
The purpose of this study was to determine the use of low-frequency ultrasound therapy on cutaneous projection of the liver in patients with type 2 DM.
Materials and Methods. 30 patients with newly diagnosed type 2 DM and body mass index (BMI) greater than
25 kg/m2 were treated by the low-frequency ultrasound therapy. The ultrasonic effects were conducted in pulsed mode of 44 kHz and an amplitude of fluctuations — 2 microns using the apparatus MIT-11 as follows. Effects on the area of liver projection in patients was performed by the immovable technique (method), exposure to a session consisted of 8 minutes. The vaseline oil was used as a contact substance. Additionally influence on segmental area of Th7-Th12 by labile technique for 2 minutes on each plot was used to enhance the therapeutic effect. The patients were examined before and after treatment. The dynamics of clinical symptoms, glycemia and glycosuria, level of glycated hemoglobin was taken into account to assess the effectiveness of low-frequency ultrasound. To assess the degree of insulin resistance content of insulin, C-peptide and glucagon in blood plasma were determined by radioimmunoassay. Fasting insulin, C-peptide, glucagon in blood serum were tested in the morning. The statistical processing of tests’ results was performed using Student’s t test.
Results. The beginning of therapeutic effect was observed after 2 procedures of the ultrasound exposure. The maximum effect is appeared after 8–10 treatment sessions. The positive dynamics of complex treatment is improving the general state of health, a disappearance of asthenization, and a decrease in the symptoms of cardiovascular disorders, achieving faster compensation of carbohydrate metabolism. The course of treatment contributed to the hyperglycemia reduction in patients with newly detected type 2 DM. After ultrasound treatment, the authors noted a positive dynamics of clinical symptoms: an improvement of the general health status, a decrease in fatigue, an improvement of psycho-emotional indices, disappearance of pain in the right upper quadrant, and a decrease in liver size in all the patients under study.
Conclusions. The use of low-frequency ultrasound therapy on cutaneous projection of the liver in patients with type 2 DM promotes the normalization both fasting and postprandial glycemia. The effect of low-frequency ultrasound on cutaneous projection of the liver is significantly decreasing parameters that characterize the pancreatic insulin synthesizing function (immunoreactive insulin, C-peptide) in patients with newly diagnosed type 2 DM and a BMI > 25 kg/m2. Low-frequency ultrasound reduces the glucagon secretion and thereby positively affects the hepatic gluconeogenesis. Ultrasound therapy can be used in the complex treatment of patients with newly diagnosed type 2 DM.
This work is licensed under a Creative Commons Attribution 4.0 International License.
Our edition uses the copyright terms of Creative Commons for open access journals.
Authors, who are published in this journal, agree with the following terms:
- The authors retain rights for authorship of their article and grant to the edition the right of first publication of the article on a Creative Commons Attribution 4.0 International License, which allows others to freely distribute the published article, with the obligatory reference to the authors of original works and original publication in this journal.
- Directing the article for the publication to the editorial board (publisher), the author agrees with transmitting of rights for the protection and using the article, including parts of the article, which are protected by the copyrights, such as the author’s photo, pictures, charts, tables, etc., including the reproduction in the media and the Internet; for distributing; for the translation of the manuscript in all languages; for export and import of the publications copies of the writers’ article to spread, bringing to the general information.
- The rights mentioned above authors transfer to the edition (publisher) for the unlimited period of validity and on the territory of all countries of the world.
- The authors guarantee that they have exclusive rights for using of the article, which they have sent to the edition (publisher). The edition (the publisher) is not responsible for the violation of given guarantees by the authors to the third parties.
- The authors have the right to conclude separate supplement agreements that relate to non-exclusive distribution of their article in the form in which it had been published in the journal (for example, to upload the work to the online storage of the journal or publish it as part of a monograph), provided that the reference to the first publication of the work in this journal is included.
- The policy of the journal permits and encourages the publication of the article in the Internet (in institutional repository or on a personal website) by the authors, because it contributes to productive scientific discussion and a positive effect on efficiency and dynamics of the citation of the article.
Amarteifio E., Wormsbecher S., Demirel S. et al. Assessment of skeletal muscle microcirculation in type 2 diabetes mellitus using dynamic contrast-enhanced ultrasound: A pilot study // Diabetes and Vascular Disease Research. — 2013. — Vol. 10, № 3. — P. 79-94.
Berger A.P., Deibl M., Halpern E.J. et al. Vascular damage induced by type 2 diabetes mellitus as a risk factor for benign prostatic hyperplasia // Diabetologia. — 2005. — Vol. 48, № 4. — P. 784-789.
Fonseca V.A. Defining and Characterizing the Progression of Type 2 Diabetes // Diabetes Care. — 2009. — Vol. 32, Suppl. 2. — S151-S156.
Nichols G.A., Hillier T.A., Brown J.B. Progression from newly acquired impaired fasting glucose to type 2 diabetes // Diabetes Care. — 2007. — Vol. 30. — P. 228-233.
Pattoneri P., Sozzi F.B., Elisabetta Catellani E. et al. Myocardial involvement during the early course of type 2 diabetes mellitus: usefulness of Myocardial Performance Index // Cardiovascular Ultrasound. — 2008. — Vol. 6. —
Valerio G., del Puente A., Buono P. et al. Quantitative ultrasound of proximal phalanxes in patients with type 1 diabetes mellitus // Diabetes Res. Clin. Pract. — 2004. — Vol. 64, № 3. — P. 161-166.